Latest Valuation News

Acumentis Group Limited has reported a robust FY2025 with a 35% jump in operating profits and declared a fully franked dividend, signaling confidence in its growth trajectory.

MIXI Australia has extended its takeover offer for PointsBet shares to 29 August 2025 and announced a conditional increase in the offer price from $1.25 to $1.30 per share, aiming to secure at least 90% ownership.

Kali Metals has successfully raised $1.2 million through a discounted share placement, aiming to boost exploration at its Marble Bar and Higginsville projects. The capital injection signals renewed momentum for the company’s gold and lithium ambitions.

NAOS Small Cap Opportunities Company Limited has declared a strong final dividend for FY25 alongside continued share buybacks, signaling confidence in its portfolio’s earnings growth and valuation potential.

PointsBet Holdings Limited has lodged its Target’s Statement advising shareholders to reject the unsolicited all-scrip takeover offer from betr Entertainment Limited, endorsing instead the competing all-cash bid from MIXI Australia. The PointsBet Board highlights significant concerns over betr’s offer, including valuation, liquidity, and conditionality.

Eureka Group Holdings Limited reported robust FY25 financial results, driven by strong rental demand and strategic acquisitions across Queensland and New South Wales. The company signals continued growth with a significant development pipeline and optimistic FY26 guidance.

Eureka Group Holdings reports robust FY25 results with double-digit revenue and profit growth, boosted by strong rental demand and strategic acquisitions. The company signals continued expansion and operational efficiency improvements ahead.

Diablo Resources is progressing exploration at its Phoenix Copper Project in Utah, targeting copper mineralisation near the producing Lisbon Valley Mine. Assay results from ongoing drilling and sampling are expected soon, supported by streamlined US permitting.

Tryptamine Therapeutics has secured an exclusive agreement with leading neuroscientists to develop a novel EEG-based brain entropy biomarker aimed at enhancing precision psychiatry for its psychedelic drug TRP-8803.

National Storage REIT delivered a solid FY25 with a 6.4% rise in underlying earnings and a robust $303 million acquisition spree, underpinning its growth ambitions amid a strong development pipeline.

Acumentis Group Limited reported a 4% revenue increase and a 35% jump in operating profit for FY25, driven by growth in corporate and private clients despite a government contract decline. The company declared a fully franked dividend and outlined a cautiously optimistic outlook for FY26.

Goodman Group delivered a robust FY25 performance, with operating profit rising 13% to $2.31 billion and a 9.8% increase in operating earnings per security. The company’s expanding data centre portfolio and strong capital position set the stage for continued growth.